172 related articles for article (PubMed ID: 15128045)
1. Role of calreticulin from parasites in its interaction with vertebrate hosts.
Ferreira V; Molina MC; Valck C; Rojas A; Aguilar L; Ramírez G; Schwaeble W; Ferreira A
Mol Immunol; 2004 Mar; 40(17):1279-91. PubMed ID: 15128045
[TBL] [Abstract][Full Text] [Related]
2. Does Trypanosoma cruzi calreticulin modulate the complement system and angiogenesis?
Ferreira V; Molina MC; Schwaeble W; Lemus D; Ferreira A
Trends Parasitol; 2005 Apr; 21(4):169-74. PubMed ID: 15780838
[TBL] [Abstract][Full Text] [Related]
3. Is It Possible to Intervene in the Capacity of
Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Menon SS; Ferreira VP; Ferreira A
Front Immunol; 2021; 12():789145. PubMed ID: 34975884
[TBL] [Abstract][Full Text] [Related]
4. Exogenous Calreticulin, incorporated onto non-infective Trypanosoma cruzi epimastigotes, promotes their internalization into mammal host cells.
Sosoniuk-Roche E; Vallejos G; Aguilar-Guzmán L; Pizarro-Bäuerle J; Weinberger K; Rosas C; Valck C; Michalak M; Ferreira A
Immunobiology; 2017 Mar; 222(3):529-535. PubMed ID: 27839837
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma carassii calreticulin binds host complement component C1q and inhibits classical complement pathway-mediated lysis.
Oladiran A; Belosevic M
Dev Comp Immunol; 2010 Apr; 34(4):396-405. PubMed ID: 19913050
[TBL] [Abstract][Full Text] [Related]
6. Roles of Trypanosoma cruzi calreticulin in parasite-host interactions and in tumor growth.
Ramírez G; Valck C; Aguilar L; Kemmerling U; López-Muñoz R; Cabrera G; Morello A; Ferreira J; Maya JD; Galanti N; Ferreira A
Mol Immunol; 2012 Oct; 52(3-4):133-40. PubMed ID: 22673211
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Trypanosoma cruzi calreticulin in the host-parasite interplay.
Ramírez G; Valck C; Ferreira VP; López N; Ferreira A
Trends Parasitol; 2011 Mar; 27(3):115-22. PubMed ID: 21288773
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin.
Valck C; Ramírez G; López N; Ribeiro CH; Maldonado I; Sánchez G; Ferreira VP; Schwaeble W; Ferreira A
Mol Immunol; 2010 Apr; 47(7-8):1516-21. PubMed ID: 20153898
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi Calreticulin Topographical Variations in Parasites Infecting Murine Macrophages.
González A; Valck C; Sánchez G; Härtel S; Mansilla J; Ramírez G; Fernández MS; Arias JL; Galanti N; Ferreira A
Am J Trop Med Hyg; 2015 May; 92(5):887-97. PubMed ID: 25758653
[TBL] [Abstract][Full Text] [Related]
10. The interaction of classical complement component C1 with parasite and host calreticulin mediates Trypanosoma cruzi infection of human placenta.
Castillo C; Ramírez G; Valck C; Aguilar L; Maldonado I; Rosas C; Galanti N; Kemmerling U; Ferreira A
PLoS Negl Trop Dis; 2013; 7(8):e2376. PubMed ID: 23991234
[TBL] [Abstract][Full Text] [Related]
11. Structural bases that underline Trypanosoma cruzi calreticulin proinfective, antiangiogenic and antitumor properties.
Peña Álvarez J; Teneb J; Maldonado I; Weinberger K; Rosas C; Lemus D; Valck C; Olivera-Nappa Á; Asenjo JA; Ferreira A
Immunobiology; 2020 Jan; 225(1):151863. PubMed ID: 31732192
[TBL] [Abstract][Full Text] [Related]
12. The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence.
Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Ferreira VP; Ferreira A
Front Immunol; 2020; 11():1561. PubMed ID: 32793217
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin.
Sosoniuk E; Vallejos G; Kenawy H; Gaboriaud C; Thielens N; Fujita T; Schwaeble W; Ferreira A; Valck C
Mol Immunol; 2014 Jul; 60(1):80-5. PubMed ID: 24769495
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma cruzi Calreticulin: Immune Evasion, Infectivity, and Tumorigenesis.
Ramírez-Toloza G; Sosoniuk-Roche E; Valck C; Aguilar-Guzmán L; Ferreira VP; Ferreira A
Trends Parasitol; 2020 Apr; 36(4):368-381. PubMed ID: 32191851
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
[TBL] [Abstract][Full Text] [Related]
16. Variable numbers of calreticulin genes in Trypanosoma cruzi correlate with atypical morphology and protein expression.
González A; Härtel S; Mansilla J; Sánchez-Valdéz F; Ferreira A
Immunobiology; 2018 Dec; 223(12):802-806. PubMed ID: 30131175
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity.
Ramírez G; Valck C; Molina MC; Ribeiro CH; López N; Sánchez G; Ferreira VP; Billetta R; Aguilar L; Maldonado I; Cattán P; Schwaeble W; Ferreira A
Immunobiology; 2011; 216(1-2):265-73. PubMed ID: 20472323
[TBL] [Abstract][Full Text] [Related]
18. Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi.
Arroyo-Olarte RD; Martínez I; Cruz-Rivera M; Mendlovic F; Espinoza B
Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170332. PubMed ID: 29513875
[TBL] [Abstract][Full Text] [Related]
19. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi.
Ferreira V; Valck C; Sánchez G; Gingras A; Tzima S; Molina MC; Sim R; Schwaeble W; Ferreira A
J Immunol; 2004 Mar; 172(5):3042-50. PubMed ID: 14978109
[TBL] [Abstract][Full Text] [Related]
20. Different Trypanosoma cruzi calreticulin domains mediate migration and proliferation of fibroblasts in vitro and skin wound healing in vivo.
Arias JI; Parra N; Beato C; Torres CG; Hamilton-West C; Rosas C; Ferreira A
Arch Dermatol Res; 2018 Oct; 310(8):639-650. PubMed ID: 30099574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
